Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference

Reviewed Reviewed

Chromatrap®, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious “Epigenetics in Drug Discovery” conference to be held in Cambridge, UK from 26th-27th January 2016.

Viewed as a new frontier in drug discovery, rapid progress has been made in enhancing understanding of epigenetic mechanisms of both new and existing drugs. With the processes that control epigenomic function providing new opportunities, epigenetics targets are enabling the discovery of novel drugs.

At the conference - Dr Amy Beynon will deliver a presentation highlighting the use of new Chromatrap solid state ChIP technology for assaying methylated and hydroxymethylated DNA marks in addition to Histone modifications and the use of Chromatrap kits for ChIP-sequencing.

Source:

http://www.chromatrap.com/

Posted in: Device / Technology News | Medical Science News | Pharmaceutical News

Tags: , , , , , , , ,

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chromatrap® - Porvair Sciences Ltd. (2019, June 24). Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference. News-Medical. Retrieved on September 26, 2023 from https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx.

  • MLA

    Chromatrap® - Porvair Sciences Ltd. "Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference". News-Medical. 26 September 2023. <https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx>.

  • Chicago

    Chromatrap® - Porvair Sciences Ltd. "Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference". News-Medical. https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx. (accessed September 26, 2023).

  • Harvard

    Chromatrap® - Porvair Sciences Ltd. 2019. Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference. News-Medical, viewed 26 September 2023, https://www.news-medical.net/news/20151221/Chromatrap-to-be-Lead-Sponsor-at-Epigenetics-in-Drug-Discovery-conference.aspx.

Suggested Reading

Precision Porous Plastic Components & Solutions
Borosilicate Glass Microplates Improve Imaging Sensitivity
High recovery of top-quality purified RNA
Lysis Buffer for High Yield Enzymatic Shearing
Handy homogeniser for cannabis sample preparation
Advances in Virus Epigenetics
Rapid Removal of gDNA from RNA Samples
Quick & easy extraction of biological & aqueous samples

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Trending Stories

More Content from Chromatrap® - Porvair Sciences Ltd

See all content from Chromatrap® - Porvair Sciences Ltd
You might also like...
Dedicated cGMP Facility for Porous Plastic Components